Long Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells

Clinical Trial Grant

Duke Scholars

Principal Investigator Taewoong Choi Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Celgene Corporation

Start Date

January 13, 2021

End Date

February 19, 2026

Administered By

Duke Cancer Institute

Awarded By

Celgene Corporation

Start Date

January 13, 2021

End Date

February 19, 2026